Danaparoid (Orgaran) as anticoagulant for autotransfusion with Cell Saver 5 (Haemonetics);Danaparoid (Orgaran) zur antikoagulation bei der maschinellen autotransfusion mit Cell Saver 5 (Haemonetics)

Anaesthesist

Volumn 50, Issue 1, 2001, Pages 26-31

  Von Lupke U ^a   Marx, A ^a   Tessmann R ^a   Lindhoff Last, E ^b  

^a Berufsgenossenschaftliche Unfallklinik Frankfurt am Main   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Anticoagulation; Autotransfusion; Cell Saver; Danaparoid; Heparin induced thrombocytopenia

Indexed keywords

DANAPAROID; HEPARIN;

ANTICOAGULATION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING; CASE REPORT; DEVICE; DRUG EFFICACY; HUMAN; THROMBOCYTOPENIA; TOTAL HIP PROSTHESIS;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD TRANSFUSION, AUTOLOGOUS; BLOOD VOLUME; CHONDROITIN SULFATES; DERMATAN SULFATE; DRUG COMBINATIONS; FACTOR XA; HEPARITIN SULFATE; HUMANS;

EID: 0034862320     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050959     Document Type: Article

References (11)

1. Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight-heparinoid anticoagulant
2. Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability
3. Heparin-elimination und freies hämoglobin nach zellseparation und waschen autologen blutes mit dem Cell-Saver 4
4. Orgaran (danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia
5. Heparin-elimination bei intraoperativer autotransfusion mit dem haemonetics cell saver
6. Aktuelle behandlungskonzepte bei heparininduzierter thrombozytopenie
7. Heparin removal in an autotransfusor device
8. Heparininduzierte gerinnungsstörung durch maschinelle autotransfusion
9. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia